Traceability, a Familiar Friend

Modern digital technologies can build in traceability from development to commercialization to optimize outcomes. As cell and gene therapy makes inroads in the life sciences marketplace, an important existing concept from this space has begun to draw more attention than it had previously: traceability.

Emerson’s Director of Life Sciences Strategy Michalle Adkins and Bob Lenich, business director of Emerson’s industrial software business share their thoughts in this article in Pharma Manufacturing magazine on traceability to ensure product efficacy.
 

Latest News

Calvin Butler to Join Emerson’s Board of Directors

Emerson today announced the appointment of Calvin Butler to its Board of Directors, effective August 1, 2024.

Emerson Reports Second Quarter 2024 Results; Updates 2024 Outlook

Emerson today reported results for the first quarter ended March 31, 2024.

Emerson’s New Flexible Control Package Helps OEMs and Small, Manufacturing Operations Develop...

The DeltaV Flex System provides scalable, subscription-based automation to reduce up-front cost and engineering complexity
Please enable JavaScript to use this website.